Aberdeen Group’s Allergan plc AGN Stock Holding History

Aberdeen Group’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-879,056	Closed	-$144M	–	817
2017 Q4	$144M	Buy	879,056 +10,579	+1%	+$1.9M	0.28%	91
2017 Q3	$178M	Buy	+868,477	New	+$202M	0.32%	78

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Aberdeen Group's AGN Position: Q1 2018 in Review

Aberdeen Group sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 879,056 shares — an estimated $144M sold.

Aberdeen Group first reported a position in AGN in Q3 2017 and held it in 2 quarters. The position peaked at $178M in Q3 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Aberdeen Group reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Aberdeen Group sold 879,056 Allergan plc shares in Q1 2018, an estimated $144M.
Aberdeen Group first reported a position in Allergan plc in Q3 2017 and held it in 2 quarters.
Aberdeen Group's Allergan plc position peaked at $178M in Q3 2017.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Aberdeen Group's 13F filing for Q1 2018, filed 15 May 2018.